Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: John Burn, Andrzej Jakubowiak, Shaji Kumar, Sagnar Lonial, Gareth Morgan, Antonio Palumbo, and Others

Premium

John Burn has been appointed as a non-executive director of NHS England, QuantuMDx said this week.

Burn serves as chief medical officer for the Newcastle, UK-based company, which is developing a series of chip-based tests. He also holds the NHS endowed chair in clinical genetics at Newcastle University.

Burn's position as non-executive director of NHS England will take effect from July 1 for a period of four years.


Dutch molecular diagnostics company SkylineDx named its scientific advisory board this week.

Members of SkylineDx's newly formed SAB include Andrzej Jakubowiak, a professor of medicine and director of the Myeloma Program at the University of Chicago; Shaji Kumar, a professor of medicine at the Mayo Clinic College of Medicine; Sagar Lonial, a trained bone marrow transplant physician with an interest in molecular therapy for lymphoma and myeloma; Gareth Morgan, director of the Myeloma Institute at the University of Arkansas for Medical Sciences; Antonio Palumbo, chief of the myeloma unit of the department of oncology at the University of Torino in Italy; David Siegel, chief of the division of multiple myeloma at Hackensack University Medical Center; Pieter Sonneveld, head of the department of hematology at Erasmus MC; and Keith Stewart, dean for research at the Mayo Clinic in Arizona.

The Scan

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.